Wird geladen...

Role of STAT3 in Transformation and Drug Resistance in CML

Chronic myeloid leukemia (CML) is initially driven by the bcr–abl fusion oncoprotein. The identification of bcr–abl led to the discovery and rapid translation into the clinic of bcr–abl kinase inhibitors. Although, bcr–abl inhibitors are efficacious, experimental evidence indicates that targeting bc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nair, Rajesh R., Tolentino, Joel H., Hazlehurst, Lori A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Research Foundation 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355894/
https://ncbi.nlm.nih.gov/pubmed/22649784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00030
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!